Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

Sage Therapeutics Inc (SG7.BE)

6.45
-0.01
(-0.15%)
At close: May 2 at 9:52:09 PM GMT+2
Loading Chart for SG7.BE
  • Previous Close 6.46
  • Open 6.60
  • Bid 6.33 x --
  • Ask 6.68 x --
  • Day's Range 6.41 - 6.63
  • 52 Week Range 4.37 - 12.99
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Jul 29, 2025 - Aug 4, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: SG7.BE

View More

Performance Overview: SG7.BE

Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SG7.BE
21.83%
S&P 500 (^GSPC)
3.31%

1-Year Return

SG7.BE
46.79%
S&P 500 (^GSPC)
12.29%

3-Year Return

SG7.BE
79.21%
S&P 500 (^GSPC)
36.85%

5-Year Return

SG7.BE
82.32%
S&P 500 (^GSPC)
100.89%

Compare To: SG7.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SG7.BE

View More

Valuation Measures

Annual
As of 5/2/2025
  • Market Cap

    403.68M

  • Enterprise Value

    39.86M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    9.43

  • Price/Book (mrq)

    1.12

  • Enterprise Value/Revenue

    0.95

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: SG7.BE

View More

Company Insights: SG7.BE

Research Reports: SG7.BE

View More